088(1)047.Pdf (377.0Kb)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Impact of Hepatitis B Surface Antigen on Natural Killer Cells In
Medizinische Fakultät der Universität Duisburg-Essen Aus der Klinik für Gastroenterologie und Hepatologie The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection Inauguraldissertation zur Erlangung des Doktorgrades der Medizin durch die Medizinische Fakultät der Universität Duisburg-Essen Vorgelegt von Yanqin Du aus Hubei, China 2020 1 Diese Dissertation wird via DuEPublico, dem Dokumenten- und Publikationsserver der Universität Duisburg-Essen, zur Verfügung gestellt und liegt auch als Print-Version vor. DOI: 10.17185/duepublico/74388 URN: urn:nbn:de:hbz:464-20210623-112949-4 Alle Rechte vorbehalten. Dekan: Herr Univ.-Prof. Dr. med. J. Buer 1. Gutachter/in: Herr Univ.-Prof. Dr. med. H. H. Wedemeyer 2. Gutachter/in: Frau Priv.-Doz. Dr. rer. nat. W. Bayer 3. Gutachter/in: Herr Prof. Dr. rer. nat. C. Watzl Tag der mündlichen Prüfung: 20. April. 2021 2 List of publication Du, Y., Anastasiou, E.O., Strunz, B., Scheuten, J., Bremer, B., Kraft A., Kleinsimglinhaus K., Todt, D., Broering, R., Hardtke-Wolenski, M., Wu, J., Yang, D., Dittmer, U., Lu, M., Cornberg, M., Björkström, K.N., Khera, T., and Wedemeyer, H. The impact of hepatitis B surface antigen on natural killer cells patients with chronic hepatitis B patients. Liver Int. 2021 Apr 1. doi: 10.1111/liv.14885. 3 Table of Contents 1. Introduction ............................................................................................................. 7 1.1. Global Prevalence and public health burden ..................................................... 7 1.2. HBV virology ..................................................................................................... 8 1.2.1. HBV structure .............................................................................................. 8 1.2.2. Viral life cycle .............................................................................................. 9 1.3. Natural history and clinical manifestation of HBV infection .......................... 10 1.3.1. -
Hepatitis B: Prevalence, Hope
Hepatitis B: Prevalence, Hope The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Hedley-Whyte, John, and Debra R Milamed. "Hepatitis B: Prevalence, Hope." The Ulster Medical Journal 88, no. 2 (2019): 118-123. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:41971766 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Ulster Med J 2019;88(2):118-123 Medical History Hepatitis B: Prevalence, Hope John Hedley-Whyte, M.D., F.A.C.P., F.R.C.A., Debra R. Milamed, M.S. Accepted: 15th January 2019 Provenance: Internally reviewed Key Words: Mentors, Virology, were responsible for wide-ranging advances in alleviation of pandemic Hepatitis B. This quartet of physician scientists INTRODUCTION each had outstanding World War II records and post-war In the transcript of his Nobel Oration for the 1976 Award in guidance: each was a personable and talented leader2,3,4,5,6,7. Physiology or Medicine, Baruch S. Blumberg refers to David EDUCATION Surrey Dane nine times.1 Dane joined the Queen’s Belfast Microbiology Department in 1955. He was soon promoted David Maurice Surrey Dane was educated at Charterhouse to Senior Lecturer, then Reader. In 1966 Dane was called to School, Surrey, England (Fig.2). In October 1942 he was a Chair of Microbiology at the University of London tenable gazetted as a Second Lieutenant in the British Army8. -
Caribbean Women in Science and Their Careers
CARIBBEAN WOMEN IN SCIENCE AND THEIR CAREERS Author: NIHERST Publisher: NIHERST Editors: Christiane Francois, Joycelyn Lee Young and Trinity Belgrave Researchers/Writers: Stacey-Ann Sarjusingh, Sasha James, Keironne Banfield-Nathaniel and Alana Xavier Design/Layout: Justin Joseph and Phoenix Productions Ltd Print: Scrip J Some of the photographs and material used in this publication were obtained from the Internet, other published documents, featured scientists and their institutions. This publication is NOT FOR SALE. Copyright August 2011 by NIHERST All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means or stored in a database or retrieval system without prior written permission of NIHERST. For further information contact: NIHERST 43-45 Woodford Street, Newtown, Port-of-Spain E-mail: [email protected] Website: www.niherst.gov.tt Telephone: 868-622-7880 Fax: 868-622-1589 ISBN 978-976-95273-6-2 Funding: Ministry of Science, Technology & Tertiary Education, Trinidad and Tobago Foreword Acknowledgements List of Abbreviations Camille Wardrop Alleyne Aerospace Engineer 6 Zulaika Ali Neonatologist 48 Frances Chandler Agronomist 8 Nita Barrow Nurse 50 Hilary Ann Robotham Westmeier Analytical Chemist 10 Susan Walker Nutritionist 52 Camille Selvon Abrahams Animator 12 Anesa Ahamad Oncologist 54 Shirin Haque Astronomer 14 Celia Christie-Samuels Paediatrician 56 Dolly Nicholas Chemist 16 Kathleen Coard Pathologist 58 Patricia Carrillo Construction Manager 18 Merle Henry Pharmacist 60 Rosalie -
Download The
ii Science as a Superpower: MY LIFELONG FIGHT AGAINST DISEASE AND THE HEROES WHO MADE IT POSSIBLE By William A. Haseltine, PhD YOUNG READERS EDITION iii Copyright © 2021 by William A. Haseltine, PhD All rights reserved. No part of this book may be used or reproduced by any means, graphic, electronic, or mechanical, including photocopying, recording, taping, or by any information storage retrieval system, without the written permission of the publisher except in the case of brief quotations embodied in critical articles and reviews. iv “If I may offer advice to the young laboratory worker, it would be this: never neglect an extraordinary appearance or happening.” ─ Alexander Fleming v CONTENTS Introduction: Science as A Superpower! ............................1 Chapter 1: Penicillin, Polio, And Microbes ......................10 Chapter 2: Parallax Vision and Seeing the World ..........21 Chapter 3: Masters, Mars, And Lasers .............................37 Chapter 4: Activism, Genes, And Late-Night Labs ........58 Chapter 5: More Genes, Jims, And Johns .........................92 Chapter 6: Jobs, Riddles, And Making A (Big) Difference ......................................................................107 Chapter 7: Fighting Aids and Aiding the Fight ............133 Chapter 8: Down to Business ...........................................175 Chapter 9: Health for All, Far and Near.........................208 Chapter 10: The Golden Key ............................................235 Glossary of Terms ..............................................................246 -
Federation Member Society Nobel Laureates
FEDERATION MEMBER SOCIETY NOBEL LAUREATES For achievements in Chemistry, Physiology/Medicine, and PHysics. Award Winners announced annually in October. Awards presented on December 10th, the anniversary of Nobel’s death. (-H represents Honorary member, -R represents Retired member) # YEAR AWARD NAME AND SOCIETY DOB DECEASED 1 1904 PM Ivan Petrovich Pavlov (APS-H) 09/14/1849 02/27/1936 for work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged. 2 1912 PM Alexis Carrel (APS/ASIP) 06/28/1873 01/05/1944 for work on vascular suture and the transplantation of blood vessels and organs 3 1919 PM Jules Bordet (AAI-H) 06/13/1870 04/06/1961 for discoveries relating to immunity 4 1920 PM August Krogh (APS-H) 11/15/1874 09/13/1949 (Schack August Steenberger Krogh) for discovery of the capillary motor regulating mechanism 5 1922 PM A. V. Hill (APS-H) 09/26/1886 06/03/1977 Sir Archibald Vivial Hill for discovery relating to the production of heat in the muscle 6 1922 PM Otto Meyerhof (ASBMB) 04/12/1884 10/07/1951 (Otto Fritz Meyerhof) for discovery of the fixed relationship between the consumption of oxygen and the metabolism of lactic acid in the muscle 7 1923 PM Frederick Grant Banting (ASPET) 11/14/1891 02/21/1941 for the discovery of insulin 8 1923 PM John J.R. Macleod (APS) 09/08/1876 03/16/1935 (John James Richard Macleod) for the discovery of insulin 9 1926 C Theodor Svedberg (ASBMB-H) 08/30/1884 02/26/1971 for work on disperse systems 10 1930 PM Karl Landsteiner (ASIP/AAI) 06/14/1868 06/26/1943 for discovery of human blood groups 11 1931 PM Otto Heinrich Warburg (ASBMB-H) 10/08/1883 08/03/1970 for discovery of the nature and mode of action of the respiratory enzyme 12 1932 PM Lord Edgar D. -
Hepatitis B: Prevalence, Hope John Hedley-Whyte, M.D., F.A.C.P., F.R.C.A., Debra R
Ulster Med J 2019;88(2):118-123 Medical History Hepatitis B: Prevalence, Hope John Hedley-Whyte, M.D., F.A.C.P., F.R.C.A., Debra R. Milamed, M.S. Accepted: 15th January 2019 Provenance: Internally reviewed Key Words: Mentors, Virology, were responsible for wide-ranging advances in alleviation of pandemic Hepatitis B. This quartet of physician scientists INTRODUCTION each had outstanding World War II records and post-war In the transcript of his Nobel Oration for the 1976 Award in guidance: each was a personable and talented leader2,3,4,5,6,7. Physiology or Medicine, Baruch S. Blumberg refers to David EDUCATION Surrey Dane nine times.1 Dane joined the Queen’s Belfast Microbiology Department in 1955. He was soon promoted David Maurice Surrey Dane was educated at Charterhouse to Senior Lecturer, then Reader. In 1966 Dane was called to School, Surrey, England (Fig.2). In October 1942 he was a Chair of Microbiology at the University of London tenable gazetted as a Second Lieutenant in the British Army8. In at the Bland-Sutton Institute and the Middlesex Hospital. 1943, Dane joined the British Parachute Regiment and was Baruch S. (Barry) Blumberg (Fig. 1), David Surrey Dane seconded to the Special Air Service (SAS). Having been (Fig. 2), Michael G.P. Stoker (Fig. 3) and Wolf Szmuness Fig 2. David Surrey Dane (1923-1998). Photograph reproduced with permission of Vox Sanguinis18 exclusively for this Medical History. After a distinguished academic career at Queen’s Belfast and London University, Professor David Surrey Dane contributed greatly to donor screening protocols to assure the safety of the British blood supply. -
Laureatai Pagal Atradimų Sritis
1 Nobelio premijų laureatai pagal atradimų sritis Toliau šioje knygoje Nobelio fiziologijos ir medicinos premijos laureatai suskirstyti pagal jų atradimus tam tikrose fiziologijos ir medicinos srityse. Vienas laureatas gali būti įrašytas keliose srityse. Akies fiziologija 1911 m. Švedų oftalmologas Allvar Gullstrand – už akies lęšiuko laužiamosios gebos tyrimus. 1967 m. Suomių ir švedų neurofiziologas Ragnar Arthur Granit, amerikiečių fiziologai Haldan Keffer Hartline ir George Wald – už akyse vykstančių pirminių fiziologinių ir cheminių procesų atradimą. Antibakteriniai vaistai 1945 m. Škotų mikrobiologas seras Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas seras Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. Audiologija 1961 m. Vengrų biofizikas Georg von Békésy – už sraigės fizinio dirginimo mechanizmo atradimą. Bakteriologija 1901 m. Vokiečių fiziologas Emil Adolf von Behring – už serumų terapijos darbus, ypač pritaikius juos difterijai gydyti (difterijos antitoksino sukūrimą). 1905 m. Vokiečių bakteriologas Heinrich Hermann Robert Koch – už tuberkuliozės tyrimus ir atradimus. 1928 m. Prancūzų bakteriologas Charles Jules Henri Nicolle – už šiltinės tyrimus. 1939 m. Vokiečių bakteriologas Gerhard Johannes Paul Domagk – už prontozilio antibakterinio veikimo atradimą. 1945 m. Škotų mikrobiologas Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. 2005 m. 2 Australų mikrobiologas Barry James Marshall ir australų patologas John Robin Warren – už bakterijos Helicobacter pylori atradimą ir jos įtakos skrandžio ir dvylikapirštės žarnos opos atsivėrimui nustatymą. -
Curriculum Vitae Prof. Dr. John Franklin Enders
Curriculum Vitae Prof. Dr. John Franklin Enders Name: John Franklin Enders Lebensdaten: 10. Februar 1897 ‐ 8. September 1985 John F. Enders war ein amerikanischer Virologe und Bakteriologe. Er war maßgeblich an der Erfor‐ schung und Entwicklung moderner Impfstoffe beteiligt. Gemeinsam mit Frederick Chapman Robbins und Thomas Huckle Weller entdeckte er die Fähigkeit des Poliovirus, in Kulturen verschiedener Ge‐ webstypen zu wachsen. Damit wurde es erstmals möglich, einen wirksamen Impfstoff gegen Kinder‐ lähmung herzustellen. Für diese Leistung wurden Enders und seine beiden Kollegen 1954 mit dem Nobelpreis für Physiologie oder Medizin ausgezeichnet. Werdegang John Enders‘ Ausbildungsweg war lang und kurvenreich: Er begann 1915 ein Studium an der Yale University, das er wegen des Ersten Weltkriegs unterbrechen musste, um als Pilot in der US‐ Luftwaffe zu dienen. 1920 schloss er sein Studium mit dem akademischen Grad eines Bachelors ab. Im Anschluss arbeitete er als Grundstücksmakler. Eine Tätigkeit, die ihn ebenso wenig befriedigte wie ein später angeschlossenes Literatur‐ und Sprachenstudium, mit dem er eigentlich eine Laufbahn als Englischlehrer angestrebt hatte. Schließlich nahm er in Yale ein Studium der Bakteriologie und Im‐ munologie auf, das er 1930 mit der Dissertation abschloss. Im Anschluss war er bis 1946 an der Yale University tätig. Neben seinen Forschungen an Mykobakterien widmete er sich der Erforschung der Pneumokokken. Seine erste Arbeit auf dem Gebiet der Virologie erschien 1939. Danach befasste er sich fast aus‐ schließlich mit Viren und untersuchte unter anderem den Wert der Gewebekulturtechnik für die Virenvermehrung. Ein wesentlicher Erfolg gelang ihm auf dem Gebiet der serologischen Technik zum Nachweis von Antikörpern des Mumpsvirus. Dazu verwendete er erstmalig ein Anti‐Gen aus infizier‐ tem Parotisgewebe von infizierten Affen. -
Prevention of Viral Hepatitis in the Nordic Countries and Germany
PUBLISHED BY THE VIRAL HEPATITIS PREVENTION BOARD (VHPB) June 2004 EDITORIAL Volume 12 - Number 3 This issue of Viral Hepatitis examines viral hepatitis prevention and control activities in CONTENTS Germany and the Nordic countries, based on conclusions that were reached during the Viral Hepatitis Prevention Board meeting, held October 13-14, 2003 in Berlin, Germany. EDITORIAL ...................................... 1 Limitations of selective risk-group immunisation Prevention of viral hepatitis in the One of the key topics for discussion during the Berlin meeting was that of hepatitis B Nordic countries immunisation targeted to risk groups. This policy has been adopted by all of the Nordic Epidemiology of hepatitis A in Sweden - the countries, based on relatively low hepatitis B virus (HBV) prevalence rates in those regions, but same old story? . .2 does not comply with the 1992 WHO recommendation that all countries include hepatitis B Hepatitis A and B outbreaks among injecting vaccination in their national universal vaccination programmes by 1997 – recommendations that drug users in the Nordic countries . .3 have been implemented by many other European Union Member States, such as Germany. Hepatitis B surveillance, epidemiology, and Besides a risk-group approach, Germany has started implementing universal hepatitis B prevention strategies in the Nordic countries . .5 vaccination programmes for infants, children, and adolescents since 1995. Problems associated with the presence of In view of continuing hepatitis B virus outbreaks, some of which can be traced to nosocomial HBsAg-positive children in day-care centres . .6 transmission and clusters of cases among young children in day-care centres, high-risk Investigation of a cluster of nosocomial immunisation strategies will need to be re-examined. -
Why So Few Nobel Prizes for Cancer Researchers?
The University of Manchester Research Why so few Nobel Prizes for cancer researchers? DOI: https://doi.org/10.1007/s00432-021-03671-x Document Version Final published version Link to publication record in Manchester Research Explorer Citation for published version (APA): Hansson, N., Padrini, G., Moll, F. H., Halling, T., & Timmermann, C. (2021). Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-021- 03671-x Published in: Journal of Cancer Research and Clinical Oncology Citing this paper Please note that where the full-text provided on Manchester Research Explorer is the Author Accepted Manuscript or Proof version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version. General rights Copyright and moral rights for the publications made accessible in the Research Explorer are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Takedown policy If you believe that this document breaches copyright please refer to the University of Manchester’s Takedown Procedures [http://man.ac.uk/04Y6Bo] or contact [email protected] providing relevant details, so we can investigate your claim. Download date:23. Sep. 2021 Journal of Cancer Research and Clinical Oncology https://doi.org/10.1007/s00432-021-03671-x ORIGINAL ARTICLE – CANCER RESEARCH Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer Nils Hansson1 · Giacomo Padrini1 · Friedrich H. -
Printwhatyoulike on ノーベル生理学・医学賞
ノーベル生理学・医学賞 出典: フリー百科事典『ウィキペディア(Wikipedia)』 ノーベル賞 > ノーベル生理学・医学賞 ノーベル生理学・医学賞(ノーベルせいりがく・いがくしょう)はノーベル賞6部門のうちの1つ。「(動物)生理学及び医学の分野で 最も重要な発見を行なった」人に与えられる。選考はカロリンスカ研究所のノーベル賞委員会が行う。 歴代受賞者 [編集] 年度 受賞者名 国籍 受賞理由 エミール・アドルフ・フォン・ 血清療法の研究、特にジフテリアに対するものによって、 1901 ベーリング ドイツ帝国 医学の新しい分野を切り開き、生理学者の手に疾病や死 年 Emil Adolf von Behring に勝利しうる手段を提供したこと 1902 ロナルド・ロス マラリアの研究によってその感染経路を示し、疾病やそれ イギリス 年 Ronald Ross に対抗する手段に関する研究の基礎を築いたこと 1903 ニールス・フィンセン 疾病の治療法への寄与、特に尋常性狼瘡への光線治療法 デンマーク 年 Niels Ryberg Finsen によって、医学の新しい領域を開拓したこと 1904 イワン・パブロフ 消化生理の研究により、その性質に関する知見を転換し ロシア連邦 年 Ivan Petrovich Pavlov 拡張したこと 1905 ロベルト・コッホ ドイツ帝国 結核に関する研究と発見 年 Robert Koch カミッロ・ゴルジ イタリア王国 Camillo Golgi 1906 神経系の構造研究 年 サンティアゴ・ラモン・イ・カ ハール スペイン Santiago Ramon y Cajal シャルル・ルイ・アルフォンス・ 1907 ラヴラン フランス 疾病発生における原虫類の役割に関する研究 年 Charles Louis Alphonse Laveran パウル・エールリヒ ドイツ帝国 1908 Paul Ehrlich 免疫の研究 年 イリヤ・メチニコフ ロシア連邦 Ilya Ilyich Mechnikov 1909 エーミール・コッハー スイス 甲状腺の生理学、病理学および外科学的研究 年 Emil Theodor Kocher 1910 アルブレヒト・コッセル 核酸物質を含む、タンパク質に関する研究による細胞化学 ドイツ帝国 年 Albrecht Kossel の知見への寄与 1911 アルヴァル・グルストランド スウェーデン 眼の屈折機能に関する研究 年 Allvar Gullstrand 1912 アレクシス・カレル フランス 血管縫合および臓器の移植に関する研究 年 Alexis Carrel 1913 シャルル・ロベール・リシェ フランス アナフィラキシーの研究 年 Charles Robert Richet 1914 ローベルト・バーラーニ オーストリア=ハンガリー 内耳系の生理学および病理学に関する研究 年 Robert Bárány 帝国 1915 受賞者なし 年 1916 受賞者なし 年 1917 受賞者なし 年 1918 受賞者なし 年 1919 ジュール・ボルデ ベルギー 免疫に関する諸発見 年 Jules Bordet アウグスト・クローグ 1920 Schack August Steenberg デンマーク 毛細血管運動に関する調整機構の発見 年 Krogh 1921 受賞者なし 年 アーチボルド・ヒル イギリス 筋肉中の熱生成に関する発見 1922 Archibald Vivian Hill 年 オットー・マイヤーホフ ドイツ 筋肉における乳酸生成と酸素消費の固定的関連の発見 Otto Fritz Meyerhof -
24 August 2013 Seminar Held
PROCEEDINGS OF THE NOBEL PRIZE SEMINAR 2012 (NPS 2012) 0 Organized by School of Chemistry Editor: Dr. Nabakrushna Behera Lecturer, School of Chemistry, S.U. (E-mail: [email protected]) 24 August 2013 Seminar Held Sambalpur University Jyoti Vihar-768 019 Odisha Organizing Secretary: Dr. N. K. Behera, School of Chemistry, S.U., Jyoti Vihar, 768 019, Odisha. Dr. S. C. Jamir Governor, Odisha Raj Bhawan Bhubaneswar-751 008 August 13, 2013 EMSSSEM I am glad to know that the School of Chemistry, Sambalpur University, like previous years is organizing a Seminar on "Nobel Prize" on August 24, 2013. The Nobel Prize instituted on the lines of its mentor and founder Alfred Nobel's last will to establish a series of prizes for those who confer the “greatest benefit on mankind’ is widely regarded as the most coveted international award given in recognition to excellent work done in the fields of Physics, Chemistry, Physiology or Medicine, Literature, and Peace. The Prize since its introduction in 1901 has a very impressive list of winners and each of them has their own story of success. It is heartening that a seminar is being organized annually focusing on the Nobel Prize winning work of the Nobel laureates of that particular year. The initiative is indeed laudable as it will help teachers as well as students a lot in knowing more about the works of illustrious recipients and drawing inspiration to excel and work for the betterment of mankind. I am sure the proceeding to be brought out on the occasion will be highly enlightening.